Indefinite Delivery Contract 36E79721D0051
- Not listed
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026. The contract will supply aripiprazole tablets in various package sizes to the VA,...
- This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The $11,065,099.45 single-award contract is for the supply of Oxcarbazepine tablets in various strengths and package sizes to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The one-year base period runs from October 14, 2024 to October 13, 2025, with four...
- The Indefinite Delivery Contract (IDC) SPE2DU25D9417 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999.00, provides a single award for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC encompasses a diverse portfolio...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, covers a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract enables the DLA to issue firm fixed-price delivery orders for branded and generic...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $4,999,999 single-award IDC, valid through December 2036, covers an extensive portfolio of branded and generic...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract, valued at $4,999,999, covers an extensive portfolio of pharmaceutical items including branded and generic...
- This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $4,999,999 single-award IDC, valid through December 2036, enables the DLA to issue firm fixed-price delivery orders...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999.00, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC enables the DLA to issue firm fixed-price delivery orders for...
- This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Avkare LLC, a pharmaceutical and medical supply company, to provide a wide range of pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a total ceiling value of $12,991,472.85 and a period of performance from March 16, 2020 to March 15, 2025. It was awarded as a...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The contract has a ceiling value of $1,423,620.00 and a period of performance from December 23, 2021 to December 22, 2026, with a one-year base period and four one-year option periods. The contract is for the delivery of dutasteride capsules to support the VA's Consolidated Mail Outpatient Pharmacy (CMOP) program and pharmaceutical distribution to VA medical centers. The contract also allows for dutasteride capsules to be supplied to the Department of Defense, Bureau of Prisons, and Indian Health Service. The contract was awarded as a single-award IDC with no set-aside, and the original solicitation was issued as a pre-solicitation notice for an unrestricted procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Exercise an Option | $0 | 10/9/25 | |
| P00005 | Exercise an Option | $0 | 12/2/24 | |
| P00004 | Supplemental Agreement for work within scope | $0 | 4/15/24 | |
| P00003 | Exercise an Option | $0 | 11/15/23 | |
| P00002 | Other Administrative Action | $0 | 5/15/23 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Dutasteride Capsules (VA-22-00001567) | 36E79721R0039 | Department of Veterans Affairs National Acquisition Center | Award Notice 3/3 | 9/15/21, 9:39 AM | |
6505--Dutasteride Capsules (VA-22-00001567) | 36E79721R0039 | Department of Veterans Affairs National Acquisition Center | Pre-Solicitation 1/3 | 6/30/21, 4:20 PM | |
6505--Dutasteride Capsules (VA-22-00001567) | 36E79721R0039 | Department of Veterans Affairs National Acquisition Center | Solicitation 2/3 | 7/15/21, 2:47 PM |